Bibliography

Found 116 results
Filters: Author is Gelman, Benjamin B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Mohammadzadeh N, Zhang N, Branton WG, Zghidi-Abouzid O, Cohen ÉA, Gelman BB, Estaquier J, Kong L, Power C. The HIV Restriction Factor Profile in the Brain Is Associated with the Clinical Status and Viral Quantities. Viruses. 2023 ;15(2).
Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, Dworkin RH, Sanders C, J McCutchan A, Archibald SL, Miller DJ, et al. HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. J Neurovirol. 2014 ;20(3):209-18.
Heaton RK, Franklin DR, Ellis RJ, J McCutchan A, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 ;17(1):3-16.
Diaz-Arrastia R, Gong Y, Kelly CJ, Gelman B. Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease. Journal of NeuroVirology [Internet]. 2004 ;10 Suppl 1:67-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14982742
Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol. 2008 ;64(5):566-72.
Schuenke KW, Gelman B. Human microglial cell isolation from adult autopsy brain: brain pH, regional variation, and infection with human immunodeficiency virus type 1. Journal of NeuroVirology [Internet]. 2003 ;9(3):346-57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12775418
I
Gelman B, Soukup VM, Schuenke KW. Increased subcortical brain lysosomal enzyme activity is correlated with decreased neurocognitive function in HIV/AIDS: A multisite analysis using the National NeuroAIDS Tissue Consortium cohort. In: Journal of Neuropathology and Experimental Neurology. Vol. 62. Journal of Neuropathology and Experimental Neurology. ; 2003. p. 539.
Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.
Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman B, Saksena NK. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Journal of Virology [Internet]. 2004 ;78(18):10133-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15331746
Gabuzda D, Yin J, Misra V, Chettimada S, Gelman BB. Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy. Viruses. 2023 ;15(4).
Woods SPaul, Rippeth JD, Frol AB, Levy JK, Ryan EL, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology [Internet]. 2004 ;26(6):759-78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15370374
Morgello S, Holzer CE, Ryan EL, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman B, Grant I, et al. Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. International Journal of Methods in Psychiatric Research [Internet]. 2006 ;15:131-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17019897
Schuenke KI, Gelman B. Isolation and HIV infection of microglia derived from autopsy brain specimens. In: Journal of NeuroVirology. Vol. 8. S1th ed. Journal of NeuroVirology. ; 2002. p. 72.
L
Mohammadzadeh N, Roda W, Branton WG, Clain J, Rabezanahary H, Zghidi-Abouzid O, Gelman BB, Angel JB, Cohen ÉA, M Gill J, et al. Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation. mBio. 2021 ;12(6):e0278421.
Ojeda-Juárez D, Shah R, Fields JAdam, Harahap-Carrillo IS, Koury J, Maung R, Gelman BB, Baaten BJ, Roberts AJ, Kaul M. Lipocalin-2 mediates HIV-1 induced neuronal injury and behavioral deficits by overriding CCR5-dependent protection. Brain Behav Immun. 2020 ;89:184-199.
Ma Q, Vaida F, Wong J, Sanders CA, Kao Y-ting, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, et al. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016 ;22(2):170-8.
Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, J McCutchan A, Simpson DM, Ellis R, et al. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 ;23(1):83-7.
Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, J McCutchan A, et al. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 ;59(4):376-81.
Fazeli PL, Moore DJ, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, et al. Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res. 2016 ;14(4):324-30.
Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JAllen, et al. Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.

Pages